NYSE: RMD
Resmed Inc Stock Ownership - Who owns Resmed?

Insider buying vs selling

Have Resmed Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael J. FarrellChairman and CEO2026-04-074,991$225.50
$1.13MSell
Michael J. FarrellChairman and CEO2026-04-074,991$146.34
$730.38kBuy
Brett SandercockChief Financial Officer2026-04-011,000$224.31
$224.31kSell
Peter C. FarrellDirector2026-04-012,000$225.00
$450.00kSell
Michael J. FarrellChairman and CEO2026-03-094,991$146.34
$730.38kBuy
Michael J. FarrellChairman and CEO2026-03-094,991$251.03
$1.25MSell
Peter C. FarrellDirector2026-03-042,000$260.22
$520.44kSell
Brett SandercockChief Financial Officer2026-03-021,000$254.30
$254.30kSell
Michael J. FarrellChairman and CEO2026-02-094,991$146.34
$730.38kBuy
Michael J. FarrellChairman and CEO2026-02-094,991$273.78
$1.37MSell

1 of 8

RMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RMD insiders and whales buy or sell their stock.

RMD Shareholders

What type of owners hold Resmed Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc12.96%18,882,403$4.31BInstitution
Blackrock Inc8.48%12,348,652$2.82BInstitution
State Street Corp4.55%6,625,408$1.51BInstitution
Bank Of New York Mellon Corp3.36%4,890,654$1.12BInstitution
Geode Capital Management LLC2.95%4,302,906$981.58MInstitution
Morgan Stanley1.98%2,891,697$659.65MInstitution
Invesco Ltd1.34%1,951,933$445.27MInstitution
Northern Trust Corp1.23%1,785,384$407.28MInstitution
Christopher G. Roberts1.17%1,700,337$387.88MInsider
First Trust Advisors LP1.04%1,517,592$346.19MInstitution

1 of 3

RMD vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RMD66.58%4.27%Net SellingNet Selling
ALC50.22%0.00%
BDX93.50%0.70%Net SellingNet Selling
WST96.23%3.77%Net SellingNet Selling
COO98.79%1.21%Net Buying

Resmed Stock Ownership FAQ

Who owns Resmed?

Resmed (NYSE: RMD) is owned by 66.58% institutional shareholders, 4.27% Resmed insiders, and 29.15% retail investors. Christopher G. Roberts is the largest individual Resmed shareholder, owning 1.70M shares representing 1.17% of the company. Christopher G. Roberts's Resmed shares are currently valued at $384.51M.

If you're new to stock investing, here's how to buy Resmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.